Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Global Wearable Biosensors Market Trends, Strategies and Forecast to 2036 Featuring Abbott Labs, Dexcom, Medtronic, Roche, Apple, Samsung Electronics Co., Garmin and Other Key PlayersCompanies: DexcomGarmin Ltd.Medtronic plcRoche HoldingSamsung Electronics"Wearable Biosensors Market - Global Forecast to 2036" has been added to ResearchAndMarkets.com's offering. According to the research report, the global wearable biosensors market is projected to reach USD 105.5 billion by 2036 from USD 35.5 billion in 2026, growing at a CAGR of 12.5% during the forecast period (2026-2036). The growth of this market is primarily driven by the escalating demand for continuous health monitoring, the rising prevalence of chronic diseases such as diabetes and cardiovascular conditions, and the increasing adoption of personalized healthcare solutions. Wearable biosensors are sophisticated devices that enable real-time tracking of physiological parameters, providing critical data for early disease detection and remote patient management. The global wearable biosensors market is undergoing a profound structural transformation as the healthcare industry shifts from episodic, clinic-based care toward continuous, proactive health management. This evolution is being catalyzed by the rapid miniaturization of sensing technologies and the integration of advanced data analytics and artificial intelligence into consumer wearables. The industry is witnessing a significant transition from simple activity trackers toward medical-grade diagnostic devices that can monitor complex biomarkers like glucose, blood pressure, and cardiac rhythms with high precision. Furthermore, the integration of wearable biosensors with digital health and telemedicine platforms is creating a seamless ecosystem for remote patient monitoring and virtual care delivery. This dynamic shift ensures sustained demand for non-invasive, user-friendly sensing solutions that empower individuals and healthcare providers with actionable health insights, ultimately improving clinical outcomes and reducing healthcare costs. Market Segmentation The global wearable biosensors market is segmented by biomarker type (glucose monitoring, heart rate and cardiac biomarkers, blood oxygen [SpO2] monitoring, blood pressure monitoring, lactate and performance biomarkers, and other biomarkers), product type/form factor (smartwatches, fitness bands, continuous glucose monitoring devices, wearable ECG monitors, smart patches, smart rings, and smart clothing), application (clinical and medical, fitness and wellness, and sports and performance monitoring), end-user (hospitals and clinics, home care settings, fitness and sports organizations, individual consumers, and research institutions), and geography. The study evaluation includes industry competitors and analyzes the market at the country level. Based on Biomarker Type By biomarker type, the glucose monitoring segment is expected to hold the largest share of the global wearable biosensors market in 2026. This dominance is attributed to the high and rising prevalence of diabetes globally and the widespread adoption of continuous glucose monitoring (CGM) systems that eliminate the need for frequent finger-prick testing. Conversely, the heart rate and cardiac biomarkers segment is projected to register significant growth, driven by the increasing integration of ECG and heart rate variability (HRV) sensing into consumer smartwatches, enabling early detection of arrhythmias and other cardiovascular conditions. Furthermore, the lactate and multi-analyte biosensors segments are projected to register the highest CAGR during the forecast period, fueled by the growing demand for performance optimization in sports and the development of non-invasive sensors for comprehensive metabolic health tracking. Based on Product Type / Form Factor By product type/form factor, the smartwatches with integrated biosensors segment is expected to hold the largest share of the global wearable biosensors market in 2026. Smartwatches have become the primary platform for health monitoring due to their high consumer acceptance, multi-functionality, and the continuous addition of medical-grade sensors by leading tech companies. Meanwhile, the continuous glucose monitoring devices segment is projected to register the highest CAGR during the forecast period. This rapid growth is driven by the shift toward proactive diabetes management and the expansion of CGM use among non-insulin-dependent patients and health-conscious individuals. Additionally, smart patches and smart rings are emerging as high-growth segments, offering discrete and specialized monitoring for clinical and wellness applications. Based on Application By application, the clinical and medical segment is expected to hold the largest share in 2026. The increasing use of wearable biosensors for chronic disease management, post-operative monitoring, and clinical trials drives this segment's leadership. Within this segment, remote patient monitoring (RPM) is a major growth catalyst. Conversely, the fitness and wellness segment is projected to register a steady growth rate, driven by the increasing consumer focus on preventive health and the popularity of activity and sleep tracking. The sports and performance monitoring segment is also witnessing rapid expansion as professional athletes and fitness enthusiasts adopt biosensors to optimize training and recovery through data-driven insights. Based on End-User By end-user, the hospitals and clinics segment is expected to hold the largest share in 2026, reflecting the primary role of healthcare providers in prescribing and managing medical-grade wearable sensors for patient care. Conversely, the home care settings segment is projected to register the highest CAGR during the forecast period. This rapid growth is driven by the global trend toward decentralized healthcare and the increasing preference for monitoring patients in their home environments to improve comfort and reduce hospital readmissions. The individual consumers segment also remains significant, as more people purchase wearables for personal health and fitness tracking. Geographic Analysis In 2026, North America is expected to account for the largest share of the global wearable biosensors market. The region's leadership is underpinned by a highly advanced healthcare infrastructure, high levels of digital health literacy, and the presence of industry leaders such as Abbott, Dexcom, Apple, and Medtronic in the United States. Furthermore, the early adoption of remote patient monitoring and a favorable reimbursement landscape for digital health technologies contribute to the market's dominance. Key companies in the North America market include Abbott Laboratories (U.S.), Dexcom, Inc. (U.S.), Apple Inc. (U.S.), Medtronic plc (Ireland), Garmin Ltd. (U.S.), Google LLC (Fitbit - U.S.), Masimo Corporation (U.S.), VitalConnect, Inc. (U.S.), and Biolinq Inc. (U.S.). Asia-Pacific is projected to witness the fastest growth during the forecast period. This expansion is primarily driven by increasing healthcare expenditure, the rapid expansion of the middle-class population, and the high penetration of smartphones and wearable devices in China, India, and Japan. Furthermore, the rising burden of chronic diseases in the region and government initiatives to promote digital health are significant catalysts. Key companies in the Asia-Pacific market include Samsung Electronics Co., Ltd. (South Korea) and various emerging local MedTech startups. Europe remains a critical market for wearable biosensors, characterized by a strong focus on preventive healthcare and the implementation of robust medical device regulations. European countries are increasingly adopting wearable sensors to address the healthcare needs of an aging population and to improve the efficiency of public health systems. The region's focus on data privacy and security is driving the demand for sensors that comply with strict GDPR and MDR standards. Key companies in the Europe market include F. Hoffmann-La Roche Ltd. (Switzerland), Oura Health Ltd. (Finland), and Empatica Inc. (U.S./Italy). Latin America is an emerging market for wearable biosensors, driven by the modernization of healthcare facilities and the increasing adoption of consumer health technologies in Brazil and Mexico. The region is seeing a shift toward more accessible health monitoring solutions as enterprises and individuals seek to manage chronic conditions more effectively. The Middle East & Africa region is experiencing growing interest in wearable biosensors as part of national digital health transformation strategies, particularly in the UAE and Saudi Arabia. Investments in high-tech healthcare infrastructure and the adoption of AI-driven health solutions are expected to be major drivers of market growth in the region. Key Players The key players operating in the global wearable biosensors market include:
- Media OutReachHong Kong Sets Out Strategies to Enhance the Appeal and Add Value to the City's Tourism IndustryEnhancing the city's appeal as a destination for tourism and major sports and cultural events was a strong focus of the First Five-Year Plan for Economic and Social Development of the Hong Kong Special Administrative Region (HKSAR) (2026-2030) and the 2026 Policy Address, announced by Hong Kong's Chief Executive John Lee last week (September 16).Enhancing the city's appeal as a destination for tourism and major sports and ...
- THE ROSEN LAW FIRM, P. A.DKS Investors Have Opportunity to Lead DICK'S Sporting Goods, Inc. Securities Fraud LawsuitNEW YORK, Sept. 21, 2026/PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of DICK'S Sporting Goods, Inc. (NYSE: DKS) between September 8, 2025 and August 24, 2026, both dates inclusive (the "Class...
- BMW GroupJ.J. Spaun triumphs at the 22nd BMW PGA Championship – Lacroix wins the new all-electric BMW iX5 with a hole-in-one.Companies: BMW+++ J.J. Spaun (USA) wins on his Wentworth debut +++ Frédéric Lacroix (FRA) secures BMW hole-in-one prize in the final round +++ More than 120,000 fans celebrate the Festival of Golf +++ The BMW PGA Championship supports the Golf Foundation +++
- Kessler Topaz Meltzer & Check, LLPINVESTOR ALERT: DICK'S Sporting Goods, Inc. (DKS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLPDid you buy DKS common stock between September 8, 2025 and August 24, 2026? Affected DKS Investor Summary Who: DICK'S Sporting Goods, Inc. (NYSE: DKS) What: Securities fraud class action lawsuit filed Class Period: September 8, 2025 through August 24, 2026 Deadline to Seek Lead Plaintiff...
- ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages DICK’S Sporting Goods, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - DKSWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of DICK’S Sporting Goods, Inc. (NYSE: DKS) between September 8, 2025 and August 24, 2026, both dates inclusive (the “Class Period”), of the important November 3, 2026 lead plaintiff deadline.
- From Sarong Music Run Sponsorship to Long-Term Commitment: JETOUR Advances Its Travel+ Strategy in MalaysiaCompanies: CheryThe Malaysia Sarong Music Run 2026 was held in Kuala Lumpur, bringing together sports, music and local cultural experiences. As the official automotive partner of the event, JETOUR organized a fleet of more than 100 vehicles for a city parade through the capital. The celebration drew a crowd of over 20,000 participants, with YAB Dato’ Seri Anwar Ibrahim, Prime Minister of Malaysia, and Ke Chuandeng, President of JETOUR International, in attendance to join this unique fusion of fitness, music and Malaysian culture.
- Fondation du Qatar - Le « Wilton Park Dialogue » appelle à une action mondiale pour favoriser le développement social par le sportCe dialogue de trois jours organisé au Royaume-Uni met l'accent sur l'autonomisation des femmes, l'inclusion et les réformes systémiques dans les pays du Sud. WEST SUSSEX, Angleterre, 19 septembre 2026 -- Des dirigeants internationaux issus des milieux gouvernementaux,...
- NYSE: DKS: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against DICK’S Sporting Goods, Inc. (DKS)Did you buy DKS common stock between September 8, 2025 and August 24, 2026?
- Qatar FoundationQatar Foundation - Wilton Park Dialogue Calls for Global Action to Drive Social Development Through SportThree-day UK dialogue emphasizes female empowerment, inclusion, and systemic reform across the Global South. — International leaders spanning government, policy, development, and sport convened at Wilton Park for a three-day dialogue...
- Circa Resort & CasinoCIRCA RESORT & CASINO AND CIRCA SPORTS ANNOUNCED AS A'S FIRST FOUNDING PARTNERMulti-year partnership brings together the A's, Circa and Circa Sports to create new fan, hospitality and community experiences Circa named as Official Resort and Sportsbook of the Athletics — The Las Vegas Athletics announced a multi-year...
- Kaplan Fox & Kilsheimer LLPKaplan Fox Encourages DICK's Sporting Goods, Inc. (DKS) Investors to Contact the Firm Before the Deadline on November 3, 2026 for a Leadership RoleKaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against DICK's Sporting Goods, Inc. ("Dick's Sporting Goods" or the "Company") (NYSE: DKS) on behalf of investors that purchased or otherwise acquired Dick's Sporting Goods common stock between September 8, 2025 and August 24, 2026 (the "Class Period").CLICK HERE TO JOIN THE CASEIf you are an investor in Dick's Sporting Goods and have suffered losses, you...